&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-05-16, 21:10

Magstim Granted EU MDR Certification
Kia Stones

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-04-03, 18:16

Minovia Therapeutics Announces FDA Clearance of Second IND Application, for a Phase II Clinical Trial of Lead Product MNV-201 in Pearson Syndrome

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-02-19, 19:05

Boehringer’s zongertinib receives Priority Review from U.S. FDA for the treatment of HER2 (ERBB2)-mutant advanced non-small cell lung cancer
Lesley Moroney

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-10-08, 18:00

Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA
Genie Cordner

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-09-26, 23:34

Minovia Therapeutics Announces FDA Clearance of IND Application for a Phase Ib Clinical Trial of MNV-201 in Low Risk Myelodysplastic Syndrome
Bradley Crotty

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2023-03-13, 22:36

KronosMD Inc CEO to attend the Annual Roth Investor

CEO Dr. Greg Rubin to meet with institutional investors...

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2023-03-09, 22:25

2023 SXSW Conference Hosts Psychedelic Healthcare VC Fund
Chandra Garran

CHICAGO and NEW YORK, March 09, 2023 (GLOBE NEWSWIRE) -- As therapeutic applications of psychedelics gain more traction in the mainstream consciousness,...

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2023-03-03, 12:33

Experts Share Insights on Evolving Global Vaccine Landscape

SINGAPORE, March 03, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trials, is...

Popular Posts